The progressive neuronal and synaptic loss typical of AD has two prominent pathological features, i.e., the abnormal accumulation of amyloid β peptide (Aβ) and the phosphorylation of tau protein in the brain [155]. This evidence concerns the gene MAPT and Alzheimer disease.